Clinical Trial

Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.

Name: Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer. — clinical trial record (NCT06894797)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The Efficacy and Safety of Long-Course Preoperative Chemoradiotherapy Combined with Consolidation or Induction NALIRIFOX Chemotherapy in the Treatment of Locally Advanced Rectal Cancer: A Prospective, Multicenter, Phase II Study.

Trial Details

NCT Number	NCT06894797
Lead Sponsor	Peking University Cancer Hospital & Institute Collaborators: CSPC Ouyi Pharmaceutical Co., Ltd.
Conditions	Locally Advanced Rectal Cancer
Enrollment	68 participants
Start Date	2025-04-01
Primary Completion	2026-10-31 (estimated)
Study Completion	2027-10-31 (estimated)
Updated on ClinicalTrials.gov	2025-03-25